Position in TGTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,316,415
+$2,549,665 QoQ
Shares Held
280,446
+23.5% QoQ
Ownership
0.183%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,690,752,415 across 354 Biotechnology names. TGTX ranks #148 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in TGTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,316,415 | 280,446 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,766,750 | 226,996 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $25,697,265 | 711,343 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $55,855,506 | 1,551,973 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $68,740,447 | 1,743,354 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $31,045,711 | 1,031,419 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $27,697,455 | 1,184,158 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $21,625,114 | 1,215,577 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $21,241,555 | 1,396,552 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $26,978,047 | 1,579,511 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,765,084 | 928,838 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $151,049,479 | 6,080,897 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $87,533,339 | 5,820,036 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $85,044,236 | 7,188,862 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $45,703,724 | 7,720,224 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $34,231,458 | 8,054,461 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $193,327,276 | 20,328,841 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $393,707,189 | 20,721,431 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $641,239,104 | 19,268,002 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $724,500,805 | 18,677,515 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $866,185,377 | 17,970,651 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $771,307,613 | 14,827,136 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $293,329,873 | 10,961,505 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $246,486,010 | 12,653,286 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $93,708,691 | 9,523,241 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||